BeStock  
Stocks › Biotechnology › GLUE

Monte Rosa Therapeutics GLUE

US equityMarket cap rank #3343Biotechnology
$10.17 +$0.30 (+3.04%)
Pre-market · Oct 8, 7:50 am ET · After hours $10.00 -1.67%
Open$9.84
Prev close$9.87
Day range$9.68 – $10.75
Volume2.08M
Market cap$867.64M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts7
Average target$28.17+177.0% vs. price
  • Buy 100%
Low $25.00Now $10.17Avg $28.17High $37.00

Recent rating changes

The last 20 actions on file set price targets from $25.00 to $37.00, averaging $30.19.

DateFirmRatingTarget
5 Oct 2026 H.C. Wainwright BUY $25.00
2 Oct 2026 LifeSci Capital BUY –
2 Oct 2026 Piper Sandler BUY $37.00
2 Oct 2026 Wedbush BUY $27.00
1 Oct 2026 Guggenheim BUY $28.00
1 Oct 2026 H.C. Wainwright BUY $25.00
8 Sep 2026 LifeSci Capital BUY –
8 Sep 2026 Guggenheim BUY $28.00
24 Aug 2026 Guggenheim BUY $28.00
12 Aug 2026 Guggenheim BUY $28.00
10 Aug 2026 J.P. Morgan BUY $27.00
7 Aug 2026 Piper Sandler BUY $37.00
6 Aug 2026 LifeSci Capital BUY –
6 Aug 2026 Guggenheim BUY $28.00
31 Jul 2026 Jefferies BUY $25.00
31 Jul 2026 Guggenheim BUY $35.00
28 Jul 2026 LifeSci Capital BUY –
15 Jul 2026 Guggenheim BUY $35.00
13 Jul 2026 Guggenheim BUY $35.00
30 Jun 2026 Guggenheim BUY $35.00

Discussion

No comments yet — be the first to weigh in on GLUE.

Leave a comment

Scroll to Top